Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-Sub Choi

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Translational Vision Science & Technology|September 14, 2021
In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal ModelsYi-Yong Baek, Bokyung Sung, Jun-Sub Choi, et al.
Plos One|July 11, 2024
An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1Seo Yun Moon, Hee Jong Kim, Jin Kwon Kim, et al.
Scientific Reports|March 20, 2025
Therapeutic potential of AAV2-shmTOR gene therapy in reducing retinal inflammation and preserving endothelial Integrity in age-related macular degenerationJin Kim, Seo Yun Moon, Ho Geun Kang, et al.
Experimental Eye Research|December 1, 2018
Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative diseaseKi-Hong Jang, Yun-Ju Do, Tae-Sung Koo, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal NeovascularizationTae Kwann Park, Si Hyung Lee, Jun Sub Choi, et al.
Experimental Eye Research|October 28, 2015
Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activationYong-Soo Byun, Young-Sik Yoo, Ji-Young Kwon, et al.
Plos One|June 16, 2022
mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathySteven Hyun Seung Lee, Joo Yong Lee, Jun-Sub Choi, et al.
Molecular Vision|May 19, 2025
Subretinal delivery of AAV5-mediated human <i>Pde6b</i> gene ameliorates the disease phenotype in a rat model of retinitis pigmentosaHee Jong Kim, Ji Hoon Kwak, Jun Sub Choi, et al.
Investigative Ophthalmology & Visual Science|February 28, 2020
Inhibition of mTOR via an AAV-Delivered shRNA Tested in a Rat OIR Model as a Potential Antiangiogenic Gene TherapySteven Hyun Seung Lee, HeeSoon Chang, Ji Hyun Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 3, 2014
Stem cell factor is a potent endothelial permeability factorJi Yeon Kim, Jun-Sub Choi, Sun-Hwa Song, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Translational Vision Science & Technology|September 14, 2021
In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal ModelsYi-Yong Baek, Bokyung Sung, Jun-Sub Choi, et al.
Plos One|July 11, 2024
An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1Seo Yun Moon, Hee Jong Kim, Jin Kwon Kim, et al.
Scientific Reports|March 20, 2025
Therapeutic potential of AAV2-shmTOR gene therapy in reducing retinal inflammation and preserving endothelial Integrity in age-related macular degenerationJin Kim, Seo Yun Moon, Ho Geun Kang, et al.
Experimental Eye Research|December 1, 2018
Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative diseaseKi-Hong Jang, Yun-Ju Do, Tae-Sung Koo, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal NeovascularizationTae Kwann Park, Si Hyung Lee, Jun Sub Choi, et al.
Experimental Eye Research|October 28, 2015
Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activationYong-Soo Byun, Young-Sik Yoo, Ji-Young Kwon, et al.
Plos One|June 16, 2022
mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathySteven Hyun Seung Lee, Joo Yong Lee, Jun-Sub Choi, et al.
Molecular Vision|May 19, 2025
Subretinal delivery of AAV5-mediated human <i>Pde6b</i> gene ameliorates the disease phenotype in a rat model of retinitis pigmentosaHee Jong Kim, Ji Hoon Kwak, Jun Sub Choi, et al.
Investigative Ophthalmology & Visual Science|February 28, 2020
Inhibition of mTOR via an AAV-Delivered shRNA Tested in a Rat OIR Model as a Potential Antiangiogenic Gene TherapySteven Hyun Seung Lee, HeeSoon Chang, Ji Hyun Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 3, 2014
Stem cell factor is a potent endothelial permeability factorJi Yeon Kim, Jun-Sub Choi, Sun-Hwa Song, et al.
Pageof 6